Biotech Struggles to Recover in 2024November 5, 2024by Adam O'DellBanyan Edge, Investment Opportunities, StocksBiotech valuations and investing peaked in late 2021, with investors surging into the sector at the height of the Covid-19 pandemic. Interest in the sector waned over the last few years — due in part to sharply increased interest rates and the rapid emergence of the AI mega trend. But now, the smart money is starting to flow back into the
sector...
Editor of Strategic Fortunes and three elite services
WHAT READERS ARE SAYING..
“I'm very Happy with your services. I hope you don't plan to retire any time soon! My retirement portfolio depends on your expert guidance. Keep up the great work! Thanks.”
- Randy
“My portfolio has grown from 275k to almost 900k with only investments made with Banyan Hill.”
- David G. (Member since 2018)
"Since I started following your secret over your multiple publications, my $659,000 account is up to $715,000 in just 2 months. I’m up $56,000 in one month alone."
- Will O.
Company not found
Please use the Find By Symbol to continue your search or Select from suggestions below